Chun‐Hao Pan

495 total citations
11 papers, 194 citations indexed

About

Chun‐Hao Pan is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Chun‐Hao Pan has authored 11 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Chun‐Hao Pan's work include Microtubule and mitosis dynamics (3 papers), Cancer Cells and Metastasis (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Chun‐Hao Pan is often cited by papers focused on Microtubule and mitosis dynamics (3 papers), Cancer Cells and Metastasis (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Chun‐Hao Pan collaborates with scholars based in United States, Colombia and China. Chun‐Hao Pan's co-authors include B‐Chen Wen, Mei‐Chih Liang, Sheng‐Kai Liang, Jen‐Chung Ko, Cindy V. Leiton, Kenneth R. Shroyer, Elizabeth A. Vanner, Ali Akalin, Richard A. Moffitt and Luisa F. Escobar‐Hoyos and has published in prestigious journals such as The Journal of Cell Biology, Cancer Research and Scientific Reports.

In The Last Decade

Chun‐Hao Pan

9 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chun‐Hao Pan United States 6 107 67 38 30 27 11 194
Ajit Elhance United States 7 114 1.1× 79 1.2× 48 1.3× 25 0.8× 25 0.9× 10 270
Xiaomeng Wang China 8 157 1.5× 97 1.4× 60 1.6× 15 0.5× 24 0.9× 12 278
Hadi Nasiri Iran 9 132 1.2× 101 1.5× 45 1.2× 7 0.2× 20 0.7× 19 283
Luciano Gastón Morosi Argentina 8 207 1.9× 60 0.9× 22 0.6× 12 0.4× 26 1.0× 11 366
Nicole Pinto Canada 11 143 1.3× 97 1.4× 54 1.4× 11 0.4× 15 0.6× 21 261
Chang Niu China 8 254 2.4× 61 0.9× 72 1.9× 14 0.5× 14 0.5× 13 329
Wolfgang Melchinger Germany 7 96 0.9× 49 0.7× 62 1.6× 16 0.5× 22 0.8× 14 222
Kebria Hezaveh Canada 8 111 1.0× 105 1.6× 33 0.9× 18 0.6× 26 1.0× 11 337
Kuldeep Singh United States 5 104 1.0× 59 0.9× 24 0.6× 6 0.2× 16 0.6× 10 205

Countries citing papers authored by Chun‐Hao Pan

Since Specialization
Citations

This map shows the geographic impact of Chun‐Hao Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Hao Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Hao Pan more than expected).

Fields of papers citing papers by Chun‐Hao Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Hao Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Hao Pan. The network helps show where Chun‐Hao Pan may publish in the future.

Co-authorship network of co-authors of Chun‐Hao Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Hao Pan. A scholar is included among the top collaborators of Chun‐Hao Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Hao Pan. Chun‐Hao Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Ghosh, Monisankar, Chun‐Hao Pan, Bo Chen, et al.. (2024). Abstract C031: Keratin 17 promotes pancreatic cancer chemoresistance through mitochondrial translocation and stabilization of dihydroorotate dehydrogenase (DHODH). Cancer Research. 84(17_Supplement_2). C031–C031.
2.
Pan, Chun‐Hao, Yan Yan, Rohit Thummalapalli, et al.. (2023). Alveolar Differentiation Drives Resistance to KRAS Inhibition in Lung Adenocarcinoma. Cancer Discovery. 14(2). 308–325. 21 indexed citations
3.
Pan, Chun‐Hao, Robert Tseng, Cindy V. Leiton, et al.. (2022). Targeting Keratin 17 in Pancreatic Cancer: A Novel Rewired Pathway of Nucleotide Metabolism that Drives Chemoresistance. The FASEB Journal. 36(S1).
4.
Snider, Justin M., et al.. (2022). Dihydroceramide desaturase 1 (DES1) promotes anchorage‐independent survival downstream of HER2‐driven glucose uptake and metabolism. The FASEB Journal. 36(10). e22558–e22558. 5 indexed citations
5.
Pan, Chun‐Hao, William E. Diehl, Jamie L. Romeiser, et al.. (2021). Neutralizing activity to SARS‐CoV‐2 of convalescent and control plasma used in a randomized controlled trial. Transfusion. 61(5). 1363–1369. 9 indexed citations
6.
Pan, Chun‐Hao, Yuka Otsuka, BanuPriya Sridharan, et al.. (2020). An unbiased high‐throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer. Molecular Oncology. 14(8). 1800–1816. 5 indexed citations
7.
Roa‐Peña, Lucia, Cindy V. Leiton, Chun‐Hao Pan, et al.. (2020). Abstract PO-050: Solubilization of keratin 17 promotes the metastatic dissemination of the most lethal form of pancreatic cancer. Cancer Research. 80(22_Supplement). PO–50. 1 indexed citations
8.
Zhang, Wen, Haiyue Jiang, Zhiyuan Chen, et al.. (2019). Cutaneous Tuberculosis and Nontuberculous Mycobacterial Infections at a National Specialized Hospital in China. Acta Dermato Venereologica. 99(11). 997–1003. 26 indexed citations
9.
Roa‐Peña, Lucia, Cindy V. Leiton, Sruthi Babu, et al.. (2019). Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer. Scientific Reports. 9(1). 11239–11239. 45 indexed citations
10.
Nowak, Dawid G., Muhan Chen, Grinu Mathew, et al.. (2019). The PHLPP2 phosphatase is a druggable driver of prostate cancer progression. The Journal of Cell Biology. 218(6). 1943–1957. 30 indexed citations
11.
Pan, Chun‐Hao, et al.. (2016). Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells. BMC Cancer. 16(1). 857–857. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026